Forward

Fostering research excellence
in EU Outermost Regions

Welcome on the Outermost Regions Research and Innovation Platform


Discover research and innovation in Outermost regions: Assets and challenges; Research and innovation communities; projects and research initiatives; infrastructures, events and news

 

Would you like a tour of the platform? (1minute)

Homepage


Search by keywords

Regional and thematic filters


Select a Region or a R&I thematic to access information

Search on the map


Visualise on a map OR partners and their research and innovation projects.

Regions


Discover the assets and Research and Innovation capacities of the Outermost regions.

Thematics


Learn about research and innovation challenges, assets and expertise in outermost regions.

R&I Communities


Learn about the OR’s research community expertise, detect collaboration opportunities and get easily in touch with research groups and other R&I partners.

Projects


Discover OR flagship projects.

Resources


Access documents, videos and media coverage related to OR Research & Innovation.

News


Stay connected to Outermost Regions by following our News page, social media.

About Forward


Learn more about the Horizon 2020 Project FORWARD : “ Fostering research excellence in EU Outermost Regions”.

Contact


Contact our dedicated team for more information regarding R&I in Outermost Regions and sign up to our newsletter.

Published 11.12.2019

jpnd_logo

JPND

ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)


Azores

 | Public Project

InnovationMedecineNeurodegenerative

Worldwide, nearly 47 million people are currently estimated to be living with dementia, and the number is expected to almost double every 20 years, yet treatments that prevent or stop the progression of neurodegeneration are still lacking. Tackling this grand challenge requires enhanced coordination of national efforts to accelerate discovery. Such synergies have been created among 30 countries in the pilot EU JPI on Neurodegenerative Disease Research (JPND). JPND has a long standing experience in collaborative actions; since 2011, a cumulated funding of 132M€ has been dedicated to competitive transnational calls and JPND is now a reference for European and global knowledge and as an innovation platform in the area of neurodegenerative diseases. Building on earlier successes of the JPND Research Strategy in scalingup and establishing synergies with Horizon 2020, there is a need to continue previous efforts to consolidate the JPND successes in defragmentation, better coordination and alignment amongst the countries, by developing new links with the EC.

JPcofuND 2 aims at launching in 2019 an ambitious call for proposals on personalised medicine, where the benefits for the patients affected with neurodegenerative diseases will be explored through personalised diagnosis, personalised prevention and personalised care. Participating countries have earmarked 24,7 M€ of national funds for this call. Moreover, to expand the impact of the project, JPND will continue to implement other actions without EU co-funding such as aligning national research strategies, making databases more accessible and interoperable, developing enabling capacities such as supportive infrastructure and platforms, capacity building, education and training. These actions are required in parallel to achieve the highest impact for the patients, their carers and for society as whole and address this grand challenge in the coming years.

Other european and international partners

  • REGIONAL FUND FOR SCIENCE AND TECHNOLOGY (AZORES-PORTUGAL)
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FRANCE)
  • SUOMEN AKATEMIA (FINLAND)
  • AGENCE NATIONALE DE LA RECHERCHE (FRANCE)
  • CANADIAN INSTITUTES OF HEALTH RESEARCH (CANADA)
  • MINISTRY OF HEALTH (ISRAEL)
  • DEUTSCHES ZENTRUM FUER LUFT – UND RAUMFAHRT EV (GERMANY)
  • FONDATION DE COOPERATION SCIENTIFIQUE MALADIE D’ALZHEIMER ET MALADIES APPARENTEEES (FRANCE)
  • FUNDACAO FOR SCIENCE AND TECHNOLOGY (PORTUGAL)
  • OSTERREICHISCHE FORSCHUNGSFORDERUNGSGESELLSCHAFT MBH (AUSTRIA)
  • FONDS NATIONAL DE LA RECHERCHE (LUXEMBOURG)
  • FEDERAAL FONDS VOOR WETENSCHAPPELIJK ONDERZOEK (BELGIUM)
  • FONDS VOOR WETENSCHAPPELIJK ONDERZOEK-VLAANDEREN (BELGIUM)
  • THE HEALTH RESEARCH BOARD (IRELAND)
  • INNOVATIONSFONDEN (DENMARK)
  • INSTITUTO DE SALUD CARLOS III (SPAIN)
  • MINISTRY OF EDUCATION YOUTH AND SPORTS (CZECHIA)
  • MINISTERO DELL’ISTRUZIONE, DELL’UNIVERSITA’ E DELLA RICERCA (ITALY)
  • MINISTRSTVO ZA IZOBRAZEVANJE, ZNANOST IN SPORT (SLOVENIA)
  • MINISTERO DELLA SALUTE (ITALY)
  • UNITED KINGDOM RESEARCH AND INNOVATION (UNITED KINGDOM)
  • NARODOWE CENTRUM NAUKI (POLAND)
  • NEMZETI KUTATASI FEJLESZTESI ES INNOVACIOS HIVATAL (HUNGARY)
  • NORGES FORSKNINGSRAD (NORWAY)
  • SCHWEIZERISCHER NATIONALFONDS ZUR FORDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG, SWITZERLAND
  • VETENSKAPSRADET – SWEDISH RESEARCH COUNCIL, SWEDEN
  • TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU, TURKEY
  • VALSTS IZGLITIBAS ATTISTIBAS AGENTURA, LATVIA
  • ZORGONDERZOEK NEDERLAND ZON, NETHERLANDS